250 related articles for article (PubMed ID: 9296223)
1. Carcinoid tumors: analysis of prognostic factors and survival in 301 patients from a referral center.
Janson ET; Holmberg L; Stridsberg M; Eriksson B; Theodorsson E; Wilander E; Oberg K
Ann Oncol; 1997 Jul; 8(7):685-90. PubMed ID: 9296223
[TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal carcinoids: characterization by site of origin and hormone production.
Onaitis MW; Kirshbom PM; Hayward TZ; Quayle FJ; Feldman JM; Seigler HF; Tyler DS
Ann Surg; 2000 Oct; 232(4):549-56. PubMed ID: 10998653
[TBL] [Abstract][Full Text] [Related]
3. Immunohistologic analysis of gastrointestinal and pulmonary carcinoid tumors.
Al-Khafaji B; Noffsinger AE; Miller MA; DeVoe G; Stemmermann GN; Fenoglio-Preiser C
Hum Pathol; 1998 Sep; 29(9):992-9. PubMed ID: 9744317
[TBL] [Abstract][Full Text] [Related]
4. Prognostic indicators for carcinoid neuroendocrine tumors of the gastrointestinal tract.
Rorstad O
J Surg Oncol; 2005 Mar; 89(3):151-60. PubMed ID: 15719376
[TBL] [Abstract][Full Text] [Related]
5. Biochemical diagnosis of neuroendocrine GEP tumor.
Oberg K
Yale J Biol Med; 1997; 70(5-6):501-8. PubMed ID: 9825477
[TBL] [Abstract][Full Text] [Related]
6. Correlation of chromogranin A levels and somatostatin receptor scintigraphy findings in the evaluation of metastases in carcinoid tumors.
Namwongprom S; Wong FC; Tateishi U; Kim EE; Boonyaprapa S
Ann Nucl Med; 2008 May; 22(4):237-43. PubMed ID: 18535873
[TBL] [Abstract][Full Text] [Related]
7. Gastrointestinal carcinoid tumors: factors that predict outcome.
Van Gompel JJ; Sippel RS; Warner TF; Chen H
World J Surg; 2004 Apr; 28(4):387-92. PubMed ID: 14994141
[TBL] [Abstract][Full Text] [Related]
8. Prognostic clinicopathologic factors in longitudinally followed patients with metastatic small bowel carcinoid tumors.
Curran T; Tulin-Silver S; Patel K; Ward S; Schneiderman M; Harpaz N; Schwartz M; Itzkowitz S; Warner RR; Kim MK
Pancreas; 2011 Nov; 40(8):1253-7. PubMed ID: 21975435
[TBL] [Abstract][Full Text] [Related]
9. Prognostic variables in patients with gastrointestinal carcinoid tumours.
McDermott EW; Guduric B; Brennan MF
Br J Surg; 1994 Jul; 81(7):1007-9. PubMed ID: 7922047
[TBL] [Abstract][Full Text] [Related]
10. Prognosis and survival in patients with gastrointestinal tract carcinoid tumors.
Shebani KO; Souba WW; Finkelstein DM; Stark PC; Elgadi KM; Tanabe KK; Ott MJ
Ann Surg; 1999 Jun; 229(6):815-21; discussion 822-3. PubMed ID: 10363895
[TBL] [Abstract][Full Text] [Related]
11. Description of patients with midgut carcinoid tumours: clinical database from a Danish centre.
Nykjaer KM; Grønbaek H; Nielsen DT; Christiansen P; Astrup LB
In Vivo; 2007; 21(4):679-84. PubMed ID: 17708366
[TBL] [Abstract][Full Text] [Related]
12. Gastrointestinal carcinoid tumors: long-term prognosis for surgically treated patients.
Söreide JA; van Heerden JA; Thompson GB; Schleck C; Ilstrup DM; Churchward M
World J Surg; 2000 Nov; 24(11):1431-6. PubMed ID: 11038218
[TBL] [Abstract][Full Text] [Related]
13. Circulating markers of prognosis and response to treatment in patients with midgut carcinoid tumours.
Turner GB; Johnston BT; McCance DR; McGinty A; Watson RG; Patterson CC; Ardill JE
Gut; 2006 Nov; 55(11):1586-91. PubMed ID: 16556667
[TBL] [Abstract][Full Text] [Related]
14. Catestatin--a novel neuropeptide in carcinoid tumors of the appendix.
Prommegger R; Ensinger C; Adlassnig C; Vaingankar S; Mahata SK; Marksteiner J; Margreiter R
Anticancer Res; 2004; 24(1):311-6. PubMed ID: 15015613
[TBL] [Abstract][Full Text] [Related]
15. Carcinoid tumour of the gastrointestinal tract: prognostic factors and disease outcome.
Agranovich AL; Anderson GH; Manji M; Acker BD; Macdonald WC; Threlfall WJ
J Surg Oncol; 1991 May; 47(1):45-52. PubMed ID: 1708841
[TBL] [Abstract][Full Text] [Related]
16. Elevated plasma chromogranin A is the first indication of recurrence in radically operated midgut carcinoid tumors.
Welin S; Stridsberg M; Cunningham J; Granberg D; Skogseid B; Oberg K; Eriksson B; Janson ET
Neuroendocrinology; 2009; 89(3):302-7. PubMed ID: 19176944
[TBL] [Abstract][Full Text] [Related]
17. Malignant carcinoid tumors. An analysis of 103 patients with regard to tumor localization, hormone production, and survival.
Norheim I; Oberg K; Theodorsson-Norheim E; Lindgren PG; Lundqvist G; Magnusson A; Wide L; Wilander E
Ann Surg; 1987 Aug; 206(2):115-25. PubMed ID: 2440390
[TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal carcinoids. Prognosis and survival.
Caprotti R; Angelini C; Mussi C; Romano F; Sartori P; Scaini A; Muselli P; Uggeri F
Minerva Chir; 2003 Aug; 58(4):523-28,529-32. PubMed ID: 14603164
[TBL] [Abstract][Full Text] [Related]
19. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.
Nikou GC; Lygidakis NJ; Toubanakis C; Pavlatos S; Tseleni-Balafouta S; Giannatou E; Mallas E; Safioleas M
Hepatogastroenterology; 2005; 52(63):731-41. PubMed ID: 15966194
[TBL] [Abstract][Full Text] [Related]
20. Small intestinal neuroendocrine tumors: prognostic factors and survival.
Bergestuen DS; Aabakken L; Holm K; Vatn M; Thiis-Evensen E
Scand J Gastroenterol; 2009; 44(9):1084-91. PubMed ID: 19572232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
